The Federal Trade Commission recently sued a wellness company over unsanctioned medical claims it was making that a line of its CBD products and supplements could treat the coronavirus and cancer.
No longer satisfied with merely sending out warning letters, the agency seems to be taking more aggressive steps to combat the scourge of companies marketing products as treatment options for conditions such as cancer and COVID-19 without supporting scientific evidence.
The California-based Whole Leafs Organic allegedly did both, according to a complaint filed in a federal district court. In advertising, it claimed that its “Thrive” nutritional supplement consisting largely of vitamin C could treat or reduce the risk of contracting the novel coronavirus, FTC said. It also sold three types of CBD products that the company said could target and eliminate cancer cells.